NASDAQ:ENGN enGene (ENGN) Stock Price, News & Analysis $9.00 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$8.52▼$9.7550-Day Range$7.70▼$13.2752-Week Range$6.69▼$43.00Volume101,260 shsAverage Volume149,315 shsMarket Capitalization$397.53 millionP/E RatioN/ADividend YieldN/APrice Target$34.40 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get enGene alerts: Email Address enGene MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside282.2% Upside$34.40 Price TargetShort InterestHealthy1.39% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.02Based on 57 Articles This WeekInsider TradingN/AProj. Earnings GrowthDecreasingFrom ($1.33) to ($1.51) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.01 out of 5 starsMedical Sector590th out of 936 stocksHolding & Other Investment Offices Industry5th out of 16 stocks 3.5 Analyst's Opinion Consensus RatingenGene has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 6 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageenGene has received no research coverage in the past 90 days.Read more about enGene's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted1.39% of the float of enGene has been sold short.Short Interest Ratio / Days to CoverenGene has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in enGene has recently increased by 7.11%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldenGene does not currently pay a dividend.Dividend GrowthenGene does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ENGN. Previous Next 1.7 News and Social Media Coverage News SentimentenGene has a news sentiment score of -0.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 57 news articles for enGene this week, compared to 22 articles on an average week.Search Interest4 people have searched for ENGN on MarketBeat in the last 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, enGene insiders have not sold or bought any company stock.Percentage Held by Insiders13.70% of the stock of enGene is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions64.16% of the stock of enGene is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about enGene's insider trading history. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for enGene are expected to decrease in the coming year, from ($1.33) to ($1.51) per share. Previous Next See Top Rated MarketRank™ Stocks Here Ad The Oxford ClubAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time to watch it.Watch Alex's "Next Magnificent Seven" presentation now. About enGene Stock (NASDAQ:ENGN)enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.Read More ENGN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ENGN Stock News HeadlinesJuly 26 at 8:51 PM | msn.comOpenAI Unveils AI Search Engine Prototype SearchGPTJuly 26 at 8:51 PM | bizjournals.comAircraft engine company to open facility in western Miami-DadeJuly 27, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.July 26 at 8:51 PM | msn.comToyota will put new engines into 100,000 Tundra trucks and Lexus SUVsJuly 26 at 8:51 PM | msn.comSearchGPT: What to know about OpenAI's AI-powered search engineJuly 26 at 3:51 PM | msn.comMotor racing-Norris leads McLaren one-two in Belgium practice, Verstappen will suffer engine penaltyJuly 26 at 3:51 PM | msn.com2 people die in single-engine plane crash in Bar Harbor, MaineJuly 26 at 3:51 PM | nytimes.comBruno Famin to leave role as Alpine F1 chief, team plans to stop making engines from 2026July 27, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.July 26 at 3:51 PM | bloomberg.comAirbus A320 Output Throttled by Leap Engine Blade IssuesJuly 26 at 8:23 AM | msn.comThe Morning After: OpenAI reveals its AI-powered search engine, SearchGPTJuly 25 at 7:53 PM | msn.comOpenAI announces a search engine called SearchGPT; Alphabet shares dipJuly 25 at 7:53 PM | msn.comOpenAI Just Announced a Search Engine, SearchGPT, but There's a CatchJuly 25 at 7:53 PM | nj.com2 people die after single-engine plane that left N.J. airport crashes in MaineJuly 25 at 7:53 PM | msn.comOpenAI wants to take on Google with a new artificial intelligence search engineJuly 25 at 7:53 PM | nytimes.comOpenAI Is Testing an A.I.-Powered Search EngineJuly 25 at 7:53 PM | msn.comOpenAI announces SearchGPT, its AI-powered search engineJuly 25 at 2:52 PM | msn.comAlphabet Stock Drops After OpenAI Introduces a Search Engine Test Called SearchGPTSee More Headlines Receive ENGN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for enGene and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings6/14/2024Today7/26/2024Fiscal Year End10/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Holding & other investment offices Sub-IndustryN/A Current SymbolNASDAQ:ENGN Previous SymbolNASDAQ:ENGN CUSIPN/A CIK1980845 Webwww.engene.com Phone302-273-0765FaxN/AEmployees31Year FoundedN/APrice Target and Rating Average Stock Price Target$34.40 High Stock Price Target$40.00 Low Stock Price Target$30.00 Potential Upside/Downside+282.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$30,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-5.65% Debt Debt-to-Equity RatioN/A Current Ratio0.01 Quick Ratio0.01 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$4.69 per share Price / Cash Flow1.92 Book Value($0.66) per share Price / Book-13.64Miscellaneous Outstanding Shares44,170,000Free Float38,115,000Market Cap$397.53 million OptionableN/A Beta-0.63 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report Key ExecutivesMr. Jason D. Hanson Esq. (Age 55)J.D., CEO & Director Comp: $656.58kDr. Alex Nichols Ph.D. (Age 38)President & COO Comp: $504.44kDr. James C. Sullivan M.Sc. (Age 45)Ph.D., Chief Scientific Officer Comp: $524.29kDr. Anthony T. Cheung Ph.D. (Age 52)Co-Founder & CTO Comp: $341.75kMr. John C. Brown D.Sc.FRSC, Ph.D., Co-Founder and Member of Scientific Advisory BoardMr. David Ryan Daws (Age 50)CFO & Head of Business Development Mr. Lee G. Giguere (Age 43)Chief Legal Officer & Corporate Secretary Ms. Sharon TanVP of Project Management & Head of Program ManagementDr. Richard P. Bryce MBChB (Age 67)MFPM, MRCGP, Chief Medical Officer Dr. Raj Pruthi M.D.Senior VP of Urologic Oncology & Clinical DevelopmentMore ExecutivesKey CompetitorsKayne Anderson BDCNYSE:KBDCBain Capital Specialty FinanceNYSE:BCSFChurchill Capital Corp VIINYSE:CVIITrinity CapitalNASDAQ:TRINAres Acquisition Co. IINYSE:AACTView All CompetitorsInsiders & InstitutionsJanus Henderson Group PLCBought 1,000,000 shares on 5/16/2024Ownership: 2.295%Altitude Crest Partners Inc.Bought 120,289 shares on 5/15/2024Ownership: 0.276%De Solidarite Des Travai FondsSold 47,854 sharesTotal: $717,810.00 ($15.00/share)De Solidarite Des Travai FondsSold 4,575 sharesTotal: $68,670.75 ($15.01/share)View All Insider TransactionsView All Institutional Transactions ENGN Stock Analysis - Frequently Asked Questions How have ENGN shares performed this year? enGene's stock was trading at $9.23 at the start of the year. Since then, ENGN stock has decreased by 2.5% and is now trading at $9.00. View the best growth stocks for 2024 here. How were enGene's earnings last quarter? enGene Holdings Inc. (NASDAQ:ENGN) announced its earnings results on Friday, June, 14th. The company reported ($0.38) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.24) by $0.14. How do I buy shares of enGene? Shares of ENGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ENGN) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored4 Steps to Survive the Coming Market CrashCracks threaten us with a widespread collapse unlike anything we've seen in our lifetime. During this prese...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding enGene Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share enGene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
